Dr. Vitti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12 Bolton Pl
Port Chester, NY 10573Phone+1 914-471-1485
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Ophthalmology, 1989 - 1992
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1988 - 1989
- State University of New York Downstate Medical Center College of MedicineClass of 1988
Certifications & Licensure
- NY State Medical License 1989 - 2025
Clinical Trials
- Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Start of enrollment: 2001 Jun 01
- Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- 156 citationsIntravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study.Yasushi Ikuno, Kyoko Ohno-Matsui, Tien Yin Wong, Jean-François Korobelnik, Robert Vitti
Ophthalmology. 2015-06-01 - 391 citationsIntravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.David M. Brown, Ursula Schmidt-Erfurth, Diana V. Do, Frank G. Holz, David S. Boyer
Ophthalmology. 2015-10-01 - 198 citationsIntravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion: Two-Year Results from the COPERNICUS StudyJeffrey S. Heier, W. Lloyd Clark, David S. Boyer, David M. Brown, Robert Vitti
Ophthalmology. 2014-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: